Public Inquiry
Infected Blood Inquiry
Status: Completed
Chair: Sir Brian Langstaff
Established: Sep 2018
Report: May 2024
Commissioned by: Cabinet Office
Examining how thousands of NHS patients were infected with HIV and Hepatitis C through contaminated blood products in the 1970s and 1980s. Found the scandal could largely have been avoided and victims were failed by the NHS, government, and blood …
IBCA compensation progress. The Infected Blood Compensation Authority publishes registration and compensation progress statistics roughly every fortnight.
Response breakdown
Data last updated: 14 Apr 2026 · Source · Data verified: 11 Jun 2026 (Claude)
Key facts
Duration: 7 years, 6 months
Total cost: £146.2m
Core participants: 2,007
Reports & milestones
Reports
Timeline
11 Jul 2017
Chair Appointed
Sir Brian Langstaff appointed as Chair.
30 Apr 2019
Hearings Begin
Public hearings commenced.
05 Apr 2023
Second Interim Re…
Second interim report with further compensation recommendations.
Show all 12 milestones
23 Aug 2024
Compensation Sche…
Infected Blood Compensation Scheme formally established.
01 Dec 2024
First Payments Ma…
First compensation payments made to eligible infected persons.
09 Jul 2025
Additional Report…
Sir Brian Langstaff published a further report focused on compensation, additional to the 20 May 2024 Inquiry Report.
· Source
21 Jul 2025
Government Respon…
Government published its response to the Inquiry's Additional Report on Compensation.
· Source
Recommendations
| Code | Recommendation | Addressed to | Response | |
|---|---|---|---|---|
| IR1-1 |
An interim payment, of no less than £100,000, should be paid to all those infected and all bereaved partners currently registered with …
|
UK Government | Accepted | View → |
Parliamentary activity
52 debates
285 questions
45 statements
13 May 2026
Early Day Motion
Redress for people impacted by surgical mesh, sodium valproate and Primodos
Sarah Green (Liberal Democrat)
Sarah Green (Liberal Democrat)
Costs
| Period | Total | Inquiry legal | CP legal | Source |
|---|---|---|---|---|
| Mar 2025 (cum.) | £146,162,778 | £67,290,993 | £27,242,761 | link |
| Mar 2025 | £5,511,059 | £1,514,906 | £603,277 | link |
| Mar 2024 | £10,301,344 | £5,354,237 | £937,131 | link |
| Mar 2023 | £28,254,992 | £11,694,492 | £7,154,110 | link |
| Mar 2022 | £32,522,939 | £15,491,533 | £5,778,813 | link |
| Mar 2021 | £34,270,948 | £20,797,365 | £4,505,612 | link |
| Mar 2020 | £25,992,907 | £9,959,119 | £5,742,876 | link |
| Mar 2019 | £9,308,693 | £2,479,341 | £2,520,943 | link |